Deal news: advising Philips on sale of its PathXL business

Deal news: advising Philips on sale of its PathXL business

Stevens & Bolton has advised Philips of the sale of its Belfast-based Digital and Computational Pathology business, formerly known as PathXL, to medical informatics and image technology company, Cirdan.

PathXL was founded in 2004 as a Queen’s University Belfast spin out company and was purchased by Philips in 2016. It offers a range of digital pathology software applications for research and education addressing growing segments of the pathology market including bio-pharma.

The Stevens & Bolton team was led by corporate partner Keith Syson, supported by Nassar Nassar (corporate), Kate Schmit (corporate tax), Kerry Garcia and Abigail Etchells (employment).

Search our site